Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 1, 2008, Pages 77-82

  Marin P ^a   Fernandez Varon E ^a   Escudero, E ^a   Vancraeynest, D ^b   Carceles C M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ORBIFLOXACIN; UNCLASSIFIED DRUG; VICTAS;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STEADY STATE;

ANIMALS; AREA UNDER CURVE; CIPROFLOXACIN; CROSS-OVER STUDIES; ESCHERICHIA COLI; FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MICROBIAL SENSITIVITY TESTS; RABBITS; STAPHYLOCOCCUS AUREUS;

ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 37549006021     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00927.x     Document Type: Article

References (37)

1. Abd El-Aty, A.M., Goudah, A., Ismail, M. Shimoda, M. (2005) Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural. Veterinary Research Communications, 29, 297 304.
2. Aliabadi, F. Lees, P. (2001) Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62, 1979 1989.
3. Aliabadi, F., Landoni, M.F. Lees, P. (2003) Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy, 47, 626 635.
4. Broome, R.L., Brooks, D.L., Babish, J.G., Copeland, D.D. Conzelman, G.M. (1991) Pharmacokinetic properties of enrofloxacin in rabbits. American Journal of Veterinary Research, 52, 1835 1841.
5. Cabanes, A., Arboix, M., Garcia Anton, J.M. Reig, F. (1992) Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090 2093.
6. Davis, J.L., Papich, M.G. Weingarten, A. (2006) The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 191 197.
7. Drusano, G.L., Johnson, D.E., Rosen, M. Standiford, H. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483 490.
8. Elmas, M., Üney, K., Yazar, E., Karabacak, A. Tras, B. (2007) Pharmacokinetics of enrofloxacin following intravenous and intramuscular administration in Angora rabbits. Research in Veterinary Science, 82, 242 245.
9. Fernández-Varón, E., Bovaira, M.J., Espuny, A., Escudero, E., Vancraeynest, D. Cárceles, C.M. (2005) Pharmacokinetic- pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Journal of Veterinary Pharmacology and Therapeutics, 28, 343 348.
10. Fernández-Varón, E., Ayala, I., Marín, P., Carrión, A., Martos, N., Escudero, E. Cárceles, C.M. (2006) Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration. Equine Veterinary Journal, 38, 342 346.
11. Fernández-Varón, E., Marín, P., Escudero, E., Vancraeynest, D. Cárceles, C.M. (2008a) Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits. Journal of Veterinary Pharmacology and Therapeutics, 30, 18 24.
12. Fernández-Varón, E., Cárceles, C.M., Marín, P., Vancraeynest, D., Montes, A., Sotillo, J. García-Martínez, J.D. (2008b) Disposition kinetics and pharmacokinetics-pharmacodynamic integration of difloxacin against Staphylococcus aureus isolates from rabbits. Research in Veterinary Science, 84, 90 94. doi: 10.1016/j.rvsc.2007.04.002.
13. Forrest, A., Nix, D.E., Ballow, C.H., Goss, T.F., Birmingham, M.C. Schentag, J.J. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy, 37, 1073 1081.
14. Ganiére, J.P., Médaille, C. Etoré, F. (2004) In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. Research in Veterinary Science, 77, 67 71.
15. Gibaldi, M. Perrier, P. (1982) Pharmacokinetics, 2nd edn. Marcel Dekker Inc., New York.
16. Hermans, K., De Herdt, P., Devriese, L.A., Hendrickx, W., Godard, C. Haesebrouck, F. (1999) Colonisation of rabbits with Staphylococcus aureus in flocks with and without chronic staphylococcosis. Veterinary Microbiology, 67, 37 46.
17. Hermans, K., Devriese, L.A. Haesebrouck, F. (2003) Rabbit staphylococcosis: difficult solutions for serious problems. Veterinary Microbiology, 91, 57 64.
18. Ibrahim, K.H., Hovde, L.B., Ross, G., Gunderson, B., Wright, D.H. Rotschafer, J.C. (2002) Microbiologic effectiveness of time- or concentration-based dosing strategies in Streptococcus pneumoniae. Diagnostic Microbiology Infectious Diseases, 44, 265 271.
19. Ihrke, P.J., Papich, M.G. Demannuelle, T.C. (1999) The use of fluoroquinolones in veterinary dermatology. Veterinary Dermatology, 10, 193 204.
20. Kalaiselvi, L., Sriranjani, D., Sriram, P. Mathuram, L.N. (2006) Pharmacokinetics of ofloxacin in broiler chicken. Journal of Veterinary Pharmacology and Therapeutics, 29, 185 189.
21. Kay-Mugford, P.A., Weingarten, A.J., Ngoh, M., Zolynas, R., White, A., Katz, T., Simmons, R. Varma, K.J. (2002) Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma. Veterinary Therapeutics, 3, 402 408.
22. Lode, H., Borner, K. Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Disease, 27, 33 39.
23. Marangos, M.N., Zhu, Z., Nicolau, D.P., Klepser, M.E. Nightingale, C.H. (1997) Disposition of ofloxacin in female New Zealand White rabbits. Journal of Veterinary Pharmacology and Therapeutics, 20, 17 20.
24. Marín, P., Escudero, E., Férnandez-Varón, E. Cárceles, C.M. (2007a) Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats. Journal of Veterinary Pharmacology and Therapeutics, 30, 74 79.
25. Marín, P., Escudero, E., Férnandez-Varón, E. Cárceles, C.M. (2007b) Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats. Journal of Dairy Science, doi: 10.3168/jds.2007-0071.
26. Nakamura, S. (1995) Veterinary use of the new quinolones in Japan. Drugs, 49 (Suppl. 2 152 158.
27. NCCLS (2002) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. NCCLS document, M31-A2 (ISBN: 1-56238-461-9). NCCLS, Suite, Wayne, PA.
28. Powers, J. (1990) Statistical analysis of pharmacokinetics data. Journal of Veterinary Pharmacology and Therapeutics, 13, 113 120.
29. Scott, D.W., Peters, J. Miller, W.H. Jr. (2006) Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs. The Canadian Veterinary Journal, 47, 999 1002.
30. Shandil, R.K., Jayaram, R., Kaur, P., Gaonkar, S., Suresh, B.L., Mahesh, B.N., Jayashree, R., Nandi, V., Bharath, S. Balasubramanian, V. (2007) Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrobial Agents and Chemotherapy, 51, 576 582.
31. Shumaker, R.C. (1986) PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabolism Reviews, 17, 331 348.
32. Siefert, H.M., Kohlsdorfer, C., Steinke, W. Witt, A. (1999) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy, 43 (Suppl. B 61 67.
33. Toutain, P.L. Lees, P. (2004) Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 467 477.
34. Turnidge, J. (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs, 58, 29 36.
35. Walker, R.D. (2000) Fluoroquinolones. In Antimicrobial Therapy in Veterinary Medicine, 3rd edn. Eds Prescott, J.F. Baggot, J.D., pp. 315 338. Iowa State University Press, Ames, IA.
36. Wright, D.H., Brown, G.H., Peterson, M.L. Rotschafer, J.C. (2000) Application of fluoroquinolone pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669 683.
37. Yamaoka, K., Tamigawara, Y. Uno, J. (1981) A pharmacokinetic analysis program (MULTI) for microcomputers. Journal of Pharmacobio-dynamics, 4, 879 885.